BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng KJ, Hsieh CM, Nepali K, Liou JP. Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye. J Med Chem 2020;63:10533-93. [PMID: 32482069 DOI: 10.1021/acs.jmedchem.9b01033] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Tian B, Bilsbury E, Doherty S, Teebagy S, Wood E, Su W, Gao G, Lin H. Ocular Drug Delivery: Advancements and Innovations. Pharmaceutics 2022;14:1931. [DOI: 10.3390/pharmaceutics14091931] [Reference Citation Analysis]
2 Fabre M, Mateo L, Lamaa D, Baillif S, Pagès G, Demange L, Ronco C, Benhida R. Recent Advances in Age-Related Macular Degeneration Therapies. Molecules 2022;27:5089. [DOI: 10.3390/molecules27165089] [Reference Citation Analysis]
3 Shao Z, Chwa M, Atilano SR, Park J, Karageozian H, Karageozian V, Kenney MC. The Transcriptome Profile of Retinal Pigment Epithelium and Müller Cell Lines Protected by Risuteganib Against Hydrogen Peroxide Stress. J Ocul Pharmacol Ther 2022. [PMID: 35731128 DOI: 10.1089/jop.2022.0015] [Reference Citation Analysis]
4 Yeung V, Boychev N, Farhat W, Ntentakis DP, Hutcheon AEK, Ross AE, Ciolino JB. Extracellular Vesicles in Corneal Fibrosis/Scarring. Int J Mol Sci 2022;23:5921. [PMID: 35682600 DOI: 10.3390/ijms23115921] [Reference Citation Analysis]
5 Fardous J, Inoue Y, Yoshida K, Ono F, Higuchi A, Ijima H. Delivery of Hydrophobic Drugs to the Posterior Ocular Region by Gel-in-Water Nanoemulsion. Transl Vis Sci Technol 2022;11:16. [PMID: 35576213 DOI: 10.1167/tvst.11.5.16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cui W, Wang Y, Luo C, Xu J, Wang K, Han H, Yao K. Nanoceria for ocular diseases: Recent advances and future prospects. Materials Today Nano 2022. [DOI: 10.1016/j.mtnano.2022.100218] [Reference Citation Analysis]
7 Bhattacharyya N, Singh S, Mukherjee D, Das N, Chatterjee A, Adhikari A, Mondal S, Mondal P, Mallick AK, Pal SK. Picosecond-resolved fluorescence resonance energy transfer (FRET) in diffuse reflectance spectroscopy explores biologically relevant hidden molecular contacts in a non-invasive way. Phys Chem Chem Phys 2022;24:6176-84. [PMID: 35229087 DOI: 10.1039/d1cp05159h] [Reference Citation Analysis]
8 Wang K, Jiang L, Zhong Y, Zhang Y, Yin Q, Li S, Zhang X, Han H, Yao K. Ferrostatin‐1‐loaded liposome for treatment of corneal alkali burn via targeting ferroptosis. Bioeng Transl Med. [DOI: 10.1002/btm2.10276] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Chauhan A, Khan T. Prodrugs - Current development and applications in ocular drug delivery. Journal of Drug Delivery Science and Technology 2021;66:102836. [DOI: 10.1016/j.jddst.2021.102836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Pu Q, Ma Q, Li J, Li G, Li XY. Soft substrate stiffness modifies corneal epithelial stem cell phenotype through hippo-YAP/notch pathway crosstalk. Med Hypotheses 2021;156:110687. [PMID: 34627046 DOI: 10.1016/j.mehy.2021.110687] [Reference Citation Analysis]
11 Marchesi N, Fahmideh F, Boschi F, Pascale A, Barbieri A. Ocular Neurodegenerative Diseases: Interconnection between Retina and Cortical Areas. Cells 2021;10:2394. [PMID: 34572041 DOI: 10.3390/cells10092394] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
12 Hsu TJ, Nepali K, Tsai CH, Imtiyaz Z, Lin FL, Hsiao G, Lai MJ, Cheng YW. The HDAC/HSP90 Inhibitor G570 Attenuated Blue Light-Induced Cell Migration in RPE Cells and Neovascularization in Mice through Decreased VEGF Production. Molecules 2021;26:4359. [PMID: 34299636 DOI: 10.3390/molecules26144359] [Reference Citation Analysis]
13 Corelli F. Has a "Chemical Magic" Opened up New Prospects for Glaucoma? J Med Chem 2021;64:8101-3. [PMID: 34019766 DOI: 10.1021/acs.jmedchem.1c00843] [Reference Citation Analysis]
14 Mincione F, Nocentini A, Supuran CT. Advances in the discovery of novel agents for the treatment of glaucoma. Expert Opin Drug Discov 2021;:1-17. [PMID: 33914670 DOI: 10.1080/17460441.2021.1922384] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
15 Lorenzo-Veiga B, Alvarez-Lorenzo C, Loftsson T, Sigurdsson HH. Age-related ocular conditions: Current treatments and role of cyclodextrin-based nanotherapies. Int J Pharm 2021;603:120707. [PMID: 33991594 DOI: 10.1016/j.ijpharm.2021.120707] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
16 Sabnis RW. Novel Heterobicyclic Carboxamides for Treating Eye Diseases. ACS Med Chem Lett 2021;12:692-3. [PMID: 34055212 DOI: 10.1021/acsmedchemlett.1c00207] [Reference Citation Analysis]
17 Kim D, Choi SW, Cho J, Been JH, Choi K, Jiang W, Han J, Oh J, Park C, Choi S, Seo S, Kim KL, Suh W, Lee SK, Kim S. Discovery of Novel Small-Molecule Antiangiogenesis Agents to Treat Diabetic Retinopathy. J Med Chem 2021;64:5535-50. [PMID: 33902285 DOI: 10.1021/acs.jmedchem.0c01965] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
18 Parsons DE, Lee SH, Sun YJ, Velez G, Bassuk AG, Smith M, Mahajan VB. Peptidomimetics Therapeutics for Retinal Disease. Biomolecules 2021;11:339. [PMID: 33668179 DOI: 10.3390/biom11030339] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
19 Spinozzi E, Baldassarri C, Acquaticci L, Del Bello F, Grifantini M, Cappellacci L, Riccardo P. Adenosine receptors as promising targets for the management of ocular diseases. Med Chem Res 2021;:1-18. [PMID: 33519168 DOI: 10.1007/s00044-021-02704-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
20 Mobaraki M, Soltani M, Zare Harofte S, L Zoudani E, Daliri R, Aghamirsalim M, Raahemifar K. Biodegradable Nanoparticle for Cornea Drug Delivery: Focus Review. Pharmaceutics 2020;12:E1232. [PMID: 33353013 DOI: 10.3390/pharmaceutics12121232] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
21 Gorantla S, Rapalli VK, Waghule T, Singh PP, Dubey SK, Saha RN, Singhvi G. Nanocarriers for ocular drug delivery: current status and translational opportunity. RSC Adv 2020;10:27835-55. [DOI: 10.1039/d0ra04971a] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]